Science
Improving treatment outcomes
Camurus uses its strong R&D expertise and proprietary FluidCrystal® technology to develop innovative long-acting treatments aimed at significantly improving the lives of people with severe and chronic diseases.
Science
Technology
Camurus’ proprietary FluidCrystal® technology is designed to provide treatment efficacy over an extended period – from days to months – with a single subcutaneous injection. This can reduce the burden of frequent dosing and provide the possibility for patients to self-administer treatment.
Science
R&D pipeline
Camurus’ R&D pipeline with programs from early to late stage development is designed to address important unmet medical needs, with the potential to make a significant difference to patients. New product candidates are based on the company's proprietary FluidCrystal® technology, developed in-house and in collaboration with international pharmaceutical companies.